A
Andrew S. Mugglin
Researcher at University of Minnesota
Publications - 23
Citations - 5626
Andrew S. Mugglin is an academic researcher from University of Minnesota. The author has contributed to research in topics: Markov chain Monte Carlo & Randomized controlled trial. The author has an hindex of 15, co-authored 21 publications receiving 4215 citations. Previous affiliations of Andrew S. Mugglin include Ohio State University & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients
Jeffrey J. Popma,G. Michael Deeb,Steven J. Yakubov,Mubashir Mumtaz,Hemal Gada,Daniel O'Hair,Tanvir Bajwa,John Heiser,William Merhi,Neal S. Kleiman,Judah Askew,Paul Sorajja,Joshua Rovin,Stanley Chetcuti,David H. Adams,P.S. Teirstein,George L. Zorn,John K. Forrest,Didier Tchetche,Jon R. Resar,Antony Walton,Nicolo Piazza,Basel Ramlawi,Newell Robinson,George Petrossian,Thomas G. Gleason,Jae K. Oh,Michael J. Boulware,Hongyan Qiao,Andrew S. Mugglin,Michael J. Reardon +30 more
TL;DR: In patients with severe aortic stenosis who were at low surgical risk, TAVR with a self‐expanding supraannular bioprosthesis was noninferior to surgery with respect to the composite end point of death or disabling stroke at 24 months.
Journal ArticleDOI
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients
Michael J. Reardon,N. M. Van Mieghem,Jeffrey J. Popma,Neal S. Kleiman,Lars Søndergaard,Mubashir Mumtaz,David H. Adams,G. M. Deeb,Brijeshwar Maini,Hemal Gada,Stanley Chetcuti,Thomas G. Gleason,John Heiser,Ruediger Lange,William Merhi,Jae Oh,Peter Skov Olsen,Nicolo Piazza,M. Williams,Stephan Windecker,Steven J. Yakubov,Eberhard Grube,Raj Makkar,Jonathan S. Lee,John V. Conte,E. Vang,Hang Nguyen,Yanping Chang,Andrew S. Mugglin,Patrick W. Serruys,Arie-Pieter Kappetein +30 more
TL;DR: TAVR was a noninferior alternative to surgery in patients with severe aortic stenosis at intermediate surgical risk, with a different pattern of adverse events associated with each procedure.
Journal ArticleDOI
Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.
Luigi Padeletti,Helmut Pürerfellner,Stuart W. Adler,Theodore J. Waller,Mark Harvey,Lewis Horvitz,Reece Holbrook,Kitty Kempen,Andrew S. Mugglin,Douglas A. Hettrick +9 more
TL;DR: The hypothesis that atrial prevention pacing algorithms could decrease AT/AF frequency in patients with atrial septal leads, bradycardia, and paroxysmal At/AF is tested.
Journal ArticleDOI
Safety and efficacy of a novel bioabsorbable, steroid‐eluting sinus stent
Andrew H. Murr,Timothy L. Smith,Peter H. Hwang,Neil Bhattacharyya,Brent J. Lanier,James W. Stambaugh,Andrew S. Mugglin,Andrew S. Mugglin +7 more
TL;DR: The study objective was to assess safety and efficacy of a steroid‐eluting sinus stent when used following functional endoscopic sinus surgery (FESS) in patients with chronic rhinosinusitis (CRS).
Journal ArticleDOI
Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure Implications for Patient Management
Robert G. Hauser,William H. Maisel,Paul A. Friedman,Linda M. Kallinen,Andrew S. Mugglin,Kapil Kumar,David O. Hodge,Thomas B. Morrison,David L. Hayes +8 more
TL;DR: Compared with Quattro leads, the survival of Fidelis leads continues to decline, and Fidelis failure is notably higher in younger patients, women, individuals with hypertrophic cardiomyopathy, and patients with arrhythmogenic right ventricular dysplasia or channelopathies.